Le Lézard
Classified in: Health, Covid-19 virus
Subject: FEA

Elekta's ProKnow to help standardize radiotherapy for veterans


ATLANTA, Feb. 10, 2021 /PRNewswire/ -- Elekta announced today that the United States Department of Veterans Affairs (VA) National Radiation Oncology Program is poised to pair its major radiotherapy quality program with Elekta's (EKTA-B.ST) ProKnow, a web browser-based cloud solution that centralizes radiotherapy data in a secure scalable platform accessible to all 41 of the VA's radiation oncology facilities nationwide.

"ProKnow is designed to give caregivers the ability to evaluate massive amounts of treatment and health data inputted into the platform's cloud server from entire populations of patients - and to share these data among their colleagues at multiple facilities," according to Larry Biscotti, Executive Vice President, North and Central America. "This should help provide the insight to standardize care with the aim of improving treatment management."

The analysis of ProKnow data leveraging the solution's available tools will help drive out variation and facilitate best practices through the standardization of care, Biscotti adds.

"ProKnow will enable remote, collaborative, 24-7 access to data, turning a healthcare network's collective data streams into a consolidated cloud-based `knowledge center' that the organization can mine for insights," he said.

VA hospitals and community health centers deliver radiotherapy to over 45,000 patients each year.

The VA is not alone in the magnitude of radiotherapy data that are accumulated on a daily basis. Radiotherapy clinics around the world generate terabytes of patient information every day. Like the VA, the insight contained within these data remains locked away without a simple, intuitive analytics solution.

"By providing a centralized and secure cloud-based solution, ProKnow can unlock the data and make it accessible, enabling any radiotherapy provider to connect to clinical teams anywhere, any time," Biscotti says. "We are particularly pleased that the VA has confidence in ProKnow, as Elekta is a proud employer of veterans and active duty military personnel, with many of our engineering and technical positions held by veterans in the US."

Notably, last year, ProKnow helped many radiation therapy departments accommodate Covid-19 restrictions - and keep their patients' treatments on track - by enabling remote plan review and contouring.

For further information, please contact:
Mattias Thorsson
Head of Corporate Communications and Public Affairs
Tel: +46 70 865 8012
e-mail: [email protected]  
Time zone: CET: Central European Time

Raven Canzeri
Global Director, Media Relations, Elekta
Tel: +1 770-670-2524
e-mail: [email protected]
Time zone: ET: Eastern Time

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-s-proknow-to-help-standardize-radiotherapy-for-veterans,c3283608

The following files are available for download:

https://mb.cision.com/Main/35/3283608/1370612.pdf

Release

 

SOURCE Elekta


These press releases may also interest you

at 16:10
SunLink Health Systems, Inc. today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third fiscal quarter ended March 31, 2024 compared to a loss from continuing operations of $453,000 (or a...

at 16:10
Starco Brands, Inc. (the "Company" or "Starco Brands") , developer and acquirer of behavior-changing technologies and brands that spark excitement in the everyday, is providing a business update in conjunction with the filing of its form 10-Q for the...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended March 31, 2024. "To...

at 16:01
Scinai Immunotherapeutics Ltd. ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing CDMO services through its Scinai Bioservices business unit, today...

at 15:06
Within the oil and gas industry, the rapid evolution of market demands, tightening environmental...



News published on and distributed by: